Author: Meir Statman
Publisher: A E I Press
ISBN:
Category : Business & Economics
Languages : en
Pages : 106
Book Description
Competition in the Pharmaceutical Industry
Author: Meir Statman
Publisher: A E I Press
ISBN:
Category : Business & Economics
Languages : en
Pages : 106
Book Description
Publisher: A E I Press
ISBN:
Category : Business & Economics
Languages : en
Pages : 106
Book Description
Competitive Problems in the Drug Industry
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities
Publisher:
ISBN:
Category : Competition, Unfair
Languages : en
Pages : 1486
Book Description
Publisher:
ISBN:
Category : Competition, Unfair
Languages : en
Pages : 1486
Book Description
Competitive Problems in the Drug Industry
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages : 288
Book Description
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages : 288
Book Description
The Pharmaceutical Industry
Author: Roy Levy
Publisher: DIANE Publishing
ISBN: 1428953639
Category : Antitrust law
Languages : en
Pages : 226
Book Description
Publisher: DIANE Publishing
ISBN: 1428953639
Category : Antitrust law
Languages : en
Pages : 226
Book Description
Competitive Problems in the Drug Industry
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
Publisher:
ISBN:
Category : Competition, Unfair
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category : Competition, Unfair
Languages : en
Pages :
Book Description
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Competitive Problems in the Pharmaceutical Drug Industry
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 240
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 240
Book Description
Competitive Problems in the Drug Industry
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
Publisher:
ISBN:
Category : Competition, Unfair
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category : Competition, Unfair
Languages : en
Pages :
Book Description
How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry
Author:
Publisher: U.S. Government Printing Office
ISBN:
Category : Business & Economics
Languages : en
Pages : 94
Book Description
Publisher: U.S. Government Printing Office
ISBN:
Category : Business & Economics
Languages : en
Pages : 94
Book Description
Code of Fair Competition for the Wholesale Drug Industry as Submitted on August 25, 1933 : Registry No. 698-2-23
Author: United States. National Recovery Administration
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 16
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 16
Book Description